Onkologie. 2010:4(5):322-325

Pancreas cancer burden of the Czech population

Edvard Geryk1, Petr Dítě1, Jan Trna1, Jiří Kozel2, Milan Konečný2, Petr Kubíček2, Radim Štampach2
1 Fakultní nemocnice, Brno
2 Geografický ústav Přírodovědecké fakulty Brno

Over the last 46 years, there were registered 56 828 cases of pancreatic cancer (PC; ICD-10: C25) in the Czech population with rate 19.1

per 100,000 males and 18,2 per 100,000 females in 2007. Between 1989–2005 the prevalence of PC increased by 45.9 % in males to 629,

by 119.1 % in females to 241. A total of 3,632 multiple PC registered in 1976–2005 in the Czech Cancer Registry there were 321 (1.5 %)

primary and 1 581 (7.4 %) subsequent in males, 241 (1.2 %) primary and 1 489 (7.7 %) subsequent in females, of which were 11 % multiple

PC of all new registered PC. Double PC were higher in females, multiple in males. The number of primary PC increased to 34 cases, of

subsequent to 258 in 2005. Almost half of multiple PC in males and third of females were registered in the age group of 35–64 years. Of

3.632 multiple PC were distributed mostly in the Northern 11.8 % and Southern 11.1 % Moravia regions and in Prague 8.1 %. The average

interval between primary PC and subsequent other neoplasms (ICD-10: C00–D48) was 3.2 years in males and 2.1 years in females, the

ratio of synchronous to metachronous cases was 1:0.7 in males and 1:0.5 in females. The most frequent cases following primary PC in

males were cancers of digestive, respiratory, urinary and genital tract, in females these were cancers of digestive, genital and urinary

tract and breast. The most frequent cancers preceding the next subsequent PC included in males primary cancers of the skin, digestive,

respiratory, urinary and genital tract, in females cancers of the skin, genital and digestive tract and breast. Up to October 2007, of 562

primary PC died 526 (93.6 %) patients and survived only 23 males and 13 females. The Czech screening programme and medical surveillance

is decisive in view of risk of multiple PC and digestive, especially colorectal cancers. The analysis of 165,050 subsequent neoplasms

in 125,262 cancer patients continue with ongoing issues.

Keywords: cancer of pancreas, incidence, prevalence, multiple malignant neoplasms, primary and subsequent cancers

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Dítě P, Trna J, Kozel J, Konečný M, Kubíček P, Štampach R. Pancreas cancer burden of the Czech population. Onkologie. 2010;4(5):322-325.
Download citation

References

  1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008. Globocan 2008. Int J Canc 2010; June 17 (v tisku).
  2. Ferlay J, Shin HR, Bray F, et al. Cancer incidence and mortality worldwide. IARC CancerBase No. 10. IARC Lyon, 2010; http://globocan.iarc.fr.
  3. Maisonnevue P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Falk Symposium 173, Brno June 4, 2010; (v tisku).
  4. Geryk E, Dítě P, Pešek M, a kol. Následné primární novotvary u 125 262 onkologicky nemocných v České republice 1976-2005. Onkologie; 2010; 3(3): 181-189.
  5. ÚZIS. Novotvary ČR. Ediční řada Zdravotnická statistika, ÚZIS ČR, 1977-2010, www.uzis.cz.
  6. Geryk E, Dítě P, Kozel J, a kol. Nádorové multiplicity u české populace. ČLČ, 2010; 149(4): 178-183.
  7. Geryk E, Dítě P, Sedláková L, a kol. Trend vícečetných nemelanomových nádorů kůže z pohledu jejich epidemiologie. Dermatologie pro praxi, 2010; 4(1): 5-9.
  8. Geryk E, Bendová M, Kozel J. Karcinom prsu a následné primární zhoubné novotvary v České republice 1976-2005. Onkologie 2009; 3(1): 54-61.
  9. Geryk E, Dítě P, Kozel J, a kol. Další primární novotvary u nemocných s karcinomem prostaty ve srovnání s jeho incidencí, mortalitou a prevalencí. Onkologie 2010; 4(2): 89-93.
  10. Stolzenberg-Solomon RZ, Fraumeni JF. jr., Wideroff L, et al. New malignancies following cancer of the digestive tract, excluding colorectal cancer. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda, MD, 2006; p. 59.
  11. Hoar SK, Wilson J, et al. Second cancer following cancer of the digestive system in Connecticut, 1935-82. Natl Canc Inst Monogr. 1985; 68: 49-82.
  12. Lynge E, Jensen OM, et al. Second cancer following cancer of the digestive system in Danmark, 1943-80. Natl Canc Inst Monogr. 1985; 68: 277-308.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.